These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1691051)

  • 1. Carboplatin in the treatment of metastatic carcinoid tumours and paraganglioma: a phase II study.
    Jodrell DI; Smith IE
    Cancer Chemother Pharmacol; 1990; 26(1):62-4. PubMed ID: 1691051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant interferon alpha-2b in patients with metastatic apudomas: effect on tumours and tumour markers.
    Biesma B; Willemse PH; Mulder NH; Verschueren RC; Kema IP; de Bruijn HW; Postmus PE; Sleijfer DT; de Vries EG
    Br J Cancer; 1992 Nov; 66(5):850-5. PubMed ID: 1384643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A phase II study of carboplatin in small cell lung cancer].
    Komatsu H; Furuse K; Nishikawa H; Minoda S; Saotome K; Nemoto E; Tani Y; Saito T; Ishiwata K; Tsutsumi M
    Gan To Kagaku Ryoho; 1988 Aug; 15(8):2313-8. PubMed ID: 2841905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of carboplatin in locally advanced and metastatic transitional cell carcinoma of the urinary bladder.
    Raabe NK; Fossa SD; Parø G
    Br J Urol; 1989 Dec; 64(6):604-7. PubMed ID: 2697452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I study of carboplatin given on a five-day intravenous schedule.
    Rozencweig M; Nicaise C; Beer M; Crespeigne N; Van Rijmenant M; Lenaz L; Kenis Y
    J Clin Oncol; 1983 Oct; 1(10):621-6. PubMed ID: 6366128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and medullary carcinoma of the thyroid with (131)I-meta-iodobenzylguanidine [(131)I-mIBG].
    Mukherjee JJ; Kaltsas GA; Islam N; Plowman PN; Foley R; Hikmat J; Britton KE; Jenkins PJ; Chew SL; Monson JP; Besser GM; Grossman AB
    Clin Endocrinol (Oxf); 2001 Jul; 55(1):47-60. PubMed ID: 11453952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression of carcinoid tumour with cyproheptadine.
    Harris AL; Smith IE
    Br Med J (Clin Res Ed); 1982 Aug; 285(6340):475. PubMed ID: 6809131
    [No Abstract]   [Full Text] [Related]  

  • 8. [Phase II study of carboplatin in genitourinary cancer. Urological Cooperative Study Group on Carboplatin].
    Niijima T; Tazaki H
    Gan To Kagaku Ryoho; 1988 Aug; 15(8):2305-11. PubMed ID: 3044277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraarterial infusion of carboplatin in the treatment of malignant gliomas: a phase II study.
    Follézou JY; Fauchon F; Chiras J
    Neoplasma; 1989; 36(3):349-52. PubMed ID: 2544815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II studies with carboplatin in non-small cell lung cancer.
    Gatzemeier U; Heckmayr M; Neuhauss R; Hossfeld D; Achterrath W; Lenaz L
    Semin Oncol; 1990 Feb; 17(1 Suppl 2):25-31. PubMed ID: 2154856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A phase II study of carboplatin to bronchogenic carcinoma of the lung. Carboplatin Cooperative Study Group for Lung Carcinoma].
    Gan To Kagaku Ryoho; 1988 Jul; 15(7):2139-44. PubMed ID: 2840036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II trial of carboplatin in patients with advanced APUD tumors.
    Saltz L; Lauwers G; Wiseberg J; Kelsen D
    Cancer; 1993 Jul; 72(2):619-22. PubMed ID: 8391382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different response to the long-acting somatostatin analogues lanreotide and octreotide in a patient with a malignant carcinoid.
    Raderer M; Kurtaran A; Scheithauer W; Fiebiger W; Weinlaender G; Oberhuber G
    Oncology; 2001; 60(2):141-5. PubMed ID: 11244329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of carboplatin in previously untreated patients with metastatic small cell lung carcinoma.
    Jacobs RH; Bitran JD; Deutsch M; Hoffman PC; Sinkule J; Purl S; Golomb HM
    Cancer Treat Rep; 1987 Mar; 71(3):311-2. PubMed ID: 3028621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase 1 study of carboplatin in patients with advanced cancer, intermittent intravenous bolus, and 24-hour infusion.
    Leyvraz S; Ohnuma T; Lassus M; Holland JF
    J Clin Oncol; 1985 Oct; 3(10):1385-92. PubMed ID: 3900302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carboplatin chemotherapy for malignant paraganglioma.
    Cairnduff F; Smith IE
    Lancet; 1986 Oct; 2(8513):982. PubMed ID: 2877163
    [No Abstract]   [Full Text] [Related]  

  • 17. Activity of sunitinib in patients with advanced neuroendocrine tumors.
    Kulke MH; Lenz HJ; Meropol NJ; Posey J; Ryan DP; Picus J; Bergsland E; Stuart K; Tye L; Huang X; Li JZ; Baum CM; Fuchs CS
    J Clin Oncol; 2008 Jul; 26(20):3403-10. PubMed ID: 18612155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of carboplatin in patients with advanced germ cell tumors refractory to cisplatin.
    Motzer RJ; Bosl GJ; Tauer K; Golbey R
    Cancer Treat Rep; 1987 Feb; 71(2):197-8. PubMed ID: 3026627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Phase II study of carboplatin in ovarian cancer].
    Kato T; Nishimura H; Yamabe T; Terashima Y; Kasamatsu T; Hirabayashi K; Nishiya I; Yajima A; Takamizawa H; Tsutsui F
    Gan To Kagaku Ryoho; 1988 Aug; 15(8):2291-6. PubMed ID: 3044275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase I-II trial of carboplatin and 5-fluorouracil combination chemotherapy in advanced carcinoma of the head and neck.
    Forastiere AA; Natale RB; Takasugi BJ; Goren MP; Vogel WC; Kudla-Hatch V
    J Clin Oncol; 1987 Feb; 5(2):190-6. PubMed ID: 3543242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.